7.2715
price down icon2.08%   -0.1685
 
loading
前日終値:
$7.44
開ける:
$7.33
24時間の取引高:
300.42K
Relative Volume:
0.13
時価総額:
$530.65M
収益:
$161.10M
当期純損益:
$-308.60M
株価収益率:
-1.5571
EPS:
-4.67
ネットキャッシュフロー:
$-259.90M
1週間 パフォーマンス:
-7.08%
1か月 パフォーマンス:
-4.52%
6か月 パフォーマンス:
-58.63%
1年 パフォーマンス:
-72.80%
1日の値動き範囲:
Value
$7.26
$7.45
1週間の範囲:
Value
$7.26
$8.15
52週間の値動き範囲:
Value
$5.90
$29.61

Arvinas Inc Stock (ARVN) Company Profile

Name
名前
Arvinas Inc
Name
セクター
Healthcare (1167)
Name
電話
203-535-1456
Name
住所
395 WINCHESTER AVE, NEW HAVEN, CT
Name
職員
430
Name
Twitter
@ArvinasInc
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
ARVN's Discussions on Twitter

ARVN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARVN
Arvinas Inc
7.27 553.27M 161.10M -308.60M -259.90M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.74 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
546.84 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
395.48 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
674.11 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.90 32.46B 3.81B -644.79M -669.77M -6.24

Arvinas Inc Stock (ARVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-02 ダウングレード Leerink Partners Outperform → Market Perform
2025-05-05 ダウングレード Truist Buy → Hold
2025-05-02 ダウングレード Jefferies Buy → Hold
2025-05-02 ダウングレード TD Cowen Buy → Hold
2025-03-13 ダウングレード Goldman Buy → Neutral
2025-03-12 ダウングレード Wedbush Outperform → Neutral
2025-03-11 ダウングレード Oppenheimer Outperform → Perform
2024-12-10 開始されました BTIG Research Buy
2024-11-18 開始されました Stephens Overweight
2024-02-28 繰り返されました Oppenheimer Outperform
2024-02-14 ダウングレード Citigroup Buy → Neutral
2024-02-01 開始されました Goldman Buy
2023-12-19 アップグレード Wells Fargo Equal Weight → Overweight
2023-12-06 アップグレード Jefferies Hold → Buy
2023-11-20 アップグレード Guggenheim Neutral → Buy
2023-10-23 アップグレード Wedbush Neutral → Outperform
2023-06-26 再開されました Oppenheimer Outperform
2023-01-12 ダウングレード Guggenheim Buy → Neutral
2023-01-03 ダウングレード Wells Fargo Overweight → Equal Weight
2022-09-09 開始されました Barclays Overweight
2022-06-21 開始されました Jefferies Hold
2022-05-09 ダウングレード Wedbush Outperform → Neutral
2022-04-28 開始されました Credit Suisse Outperform
2022-04-06 開始されました Morgan Stanley Equal-Weight
2022-02-11 再開されました BMO Capital Markets Outperform
2022-02-10 開始されました Wells Fargo Overweight
2022-01-19 開始されました Goldman Buy
2021-12-07 開始されました Cowen Outperform
2021-10-14 開始されました SVB Leerink Outperform
2021-09-30 開始されました Stifel Buy
2021-09-09 開始されました BofA Securities Buy
2021-05-21 開始されました UBS Buy
2021-04-21 開始されました Truist Buy
2021-03-31 開始されました BMO Capital Markets Outperform
2020-12-14 アップグレード Oppenheimer Perform → Outperform
2020-06-01 アップグレード Citigroup Neutral → Buy
2020-05-12 開始されました Oppenheimer Perform
2019-12-19 開始されました H.C. Wainwright Buy
2019-11-25 開始されました Guggenheim Buy
2019-10-24 アップグレード Goldman Neutral → Buy
2019-09-25 開始されました Wedbush Outperform
2019-09-12 開始されました BMO Capital Markets Outperform
2019-08-06 開始されました Cantor Fitzgerald Overweight
2019-06-05 ダウングレード Citigroup Buy → Neutral
2019-04-12 開始されました Evercore ISI Outperform
2018-10-22 開始されました Citigroup Buy
2018-10-22 開始されました Goldman Neutral
2018-10-22 開始されました Piper Jaffray Overweight
すべてを表示

Arvinas Inc (ARVN) 最新ニュース

pulisher
Jul 31, 2025

What catalysts could drive Arvinas Inc. stock higher in 2025Earnings Report Updates That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Arvinas (NASDAQ:ARVN) Stock Price Up 8.6%Here's Why - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Arvinas, Inc. (NASDAQ:ARVN) Shares Acquired by Monaco Asset Management SAM - MarketBeat

Jul 31, 2025
pulisher
Jul 30, 2025

Is Arvinas Inc. the Top Chart Pick This WeekBig Return Stock Tips - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Arvinas, Inc. to Host Q2 2025 Financial Results and Corporate Update Webcast on August 6, 2025 - Quiver Quantitative

Jul 30, 2025
pulisher
Jul 30, 2025

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewswire

Jul 30, 2025
pulisher
Jul 30, 2025

Protein Degradation Pioneer Arvinas Sets Q2 2025 Earnings Report DateKey Details Inside - Stock Titan

Jul 30, 2025
pulisher
Jul 30, 2025

Using data filters to optimize entry into Arvinas Inc.News Based Entry Opportunity Alerts Detected - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

What makes Arvinas Inc. stock price move sharplyHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Watch for Bullish Crossover in Arvinas Inc.Risk Adjusted Technical Entry Plan Gains Followers - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Technical Bounce Expected in Arvinas Inc. Next WeekTriple Digit Growth Focused Trade Plan Reviewed - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 03:00:57 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

ESR1 Mutated Metastatic Breast Cancer Market to Expand Significantly by 2034, States DelveInsight Report | Sanofi, Sun Pharma, Zenopharm, Arvinas, Sermonix Pharma, H3 Biomedicine, Radius Pharma - Barchart.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Arvinas Inc. generate profit in a changing economyMaximize returns with strategic trading plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why Arvinas Inc. stock attracts strong analyst attentionReversal Alert Based on RSI Indicator Confirmed - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Key External Factors That Drive Arvinas Inc. Stock Price MovementsFree Elite Traders Group - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What markets is Arvinas Inc. expanding into Is ESTA stock a good long term investment optionExceptional gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How Resilient Is Arvinas Inc. Stock During Economic Downturns10x Return With Managed Risk - metal.it

Jul 28, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Arvinas Inc.Breakthrough stock performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Arvinas Inc.Skyrocketing investment returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Arvinas Inc. stockGet real-time alerts on top stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Arvinas (ARVN) to Release Quarterly Earnings on Tuesday - MarketBeat

Jul 26, 2025
pulisher
Jul 25, 2025

What drives Arvinas Inc. stock priceFree Trend-Following Techniques - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Arvinas Inc. stockLightning-fast growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

How high can Arvinas Inc. stock price go in 2025Skyrocketing investment returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is Arvinas Inc. a good long term investmentFree Buy/Sell Signal Notifications - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Arvinas, Inc. (ARVN): A Bull Case Theory - Insider Monkey

Jul 24, 2025
pulisher
Jul 23, 2025

Arvinas Inc. Stock Analysis and ForecastPhenomenal trading returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 20, 2025

Arvinas Presents Promising Preclinical Data for BCL6 Degrader ARV-393 in Lymphoma Treatment - MSN

Jul 20, 2025

Arvinas Inc (ARVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$74.38
price down icon 0.64%
$36.74
price up icon 0.01%
$107.06
price down icon 0.08%
$26.26
price down icon 0.63%
$105.68
price down icon 1.79%
biotechnology ONC
$295.11
price down icon 2.29%
大文字化:     |  ボリューム (24 時間):